Andera Partners

What they fund

• Life Sciences Growth — Late-stage biotech and medtech companies, exemplified by the $20 million Series D in Rivermark Medical [1]., - MidCap Buyouts & Growth — Established European companies seeking expansion, such as Tecnikabel's US expansion via EIS Wire & Cable acquisition [1]., - Sponsored Buyouts — Management-led transactions in sectors like travel and payments, evidenced by investments in S4BT and exceet Card Group [1]., - Infrastructure — Energy and infrastructure assets, shown by the sale of Nostrum Group to IREN [1].

Investment thesis

Andera Partners operates as a multi-strategy private equity firm with a partnership-based model, aiming to help companies and management achieve strong and sustainable growth through bespoke solutions tailored to specific business challenges [1].

• Life Sciences Leadership — The firm is deeply committed to the life sciences sector, evidenced by its leadership in a $20 million Series D financing for Rivermark Medical and the acquisition of Tubulis by Gilead [1].
• Multi-Strategy Approach — Andera deploys capital across distinct strategies including Life Sciences, MidCap, Expansion, Acto (sponsored buyouts), and Infra, allowing it to address diverse growth and adaptation challenges [1].
• Sustainable Growth Focus — The firm emphasizes long-term value creation, highlighted by its 2025 Sustainability Report and its strategic move to sell its stake in Nostrum Group to IREN [1].

Credibility: Homepage details the multi-strategy model, specific portfolio exits (Tubulis/Gilead), and recent news items including the Rivermark Medical financing and Nostrum Group sale [1].

Value add

Andera Partners provides bespoke solutions and strategic guidance to management teams, leveraging its 131 professionals and multi-strategy expertise to address specific business challenges [1].

Fit verdict: Ideal for growth-stage life sciences companies and midcap industrial firms seeking a long-term private equity partner with deep sector expertise and a partnership-oriented approach.

Founder diligence script:

• How does Andera's multi-strategy structure (Life Sciences, MidCap, Acto, Infra) impact decision-making and resource allocation for my specific deal?
• What specific operational support does the firm provide to portfolio companies, particularly in life sciences and industrial sectors?
• How does Andera measure and report on sustainability and ESG metrics, as highlighted in its 2025 Sustainability Report?

Portfolio focus

• Life Sciences — Tubulis (acquired by Gilead), Agomab (Nasdaq listing), and Rivermark Medical (Series D financing) [1]., - Industrial & Infrastructure — Tecnikabel (acquired EIS Wire & Cable), Nostrum Group (sold to IREN), and HotelHub (acquired by S4BT) [1]., - Sponsored Buyouts (Acto) — exceet Card Group (Austrian company) and S4BT (global business travel) [1].

Notable investments & exits

• Tubulis — Acquired by Gilead, adding a potentially best-in-class asset to Gilead's portfolio [1]., - Nostrum Group — Andera Infra sold its stake in Nostrum Group to IREN, a company listed on the NASDAQ [1]., - Agomab — Portfolio company completed a successful Nasdaq listing with a $200 million raise [1].

Strategic implications

Andera's multi-strategy model allows it to diversify risk and capture opportunities across different market cycles, particularly in life sciences and midcap buyouts. The 40% stake held by New York Life Investments provides Andera with significant financial backing and access to institutional capital, enhancing its ability to deploy large sums. The firm's focus on sustainability and ESG, as highlighted by its 2025 Sustainability Report, positions it well to attract LPs with strong ESG mandates.

Where they could go further

Andera could expand its life sciences strategy into earlier-stage ventures to capture higher growth potential and build a deeper pipeline of exit candidates., The firm should leverage its New York Life Investments partnership to explore co-investment opportunities in the US market, particularly in life sciences and infrastructure., Andera could enhance its value-add proposition by establishing a dedicated operational excellence team to support portfolio companies in digital transformation and supply chain optimization.